Retraction: Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice [Clinical Science, 122, 2, (2012) (83-92)] DOI: 10.1042/CS20110295;Transgenic expression of human matrix metalloproteinase-I attenuates pulmonary arterial hypertension in mice

Clinical Science

Volumn 122, Issue 2, 2012, Pages 83-92

  George, Joseph ^a   Sun, Jie ^a   D'Armiento, Jeanine ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Matrix metalloproteinase 1 (MMP I) transgene; Monocrotaline; Occlusion; Pulmonary arterial hypertension

Indexed keywords

COLLAGEN; INTERSTITIAL COLLAGENASE; ACTIN; ALPHA SMOOTH MUSCLE ACTIN, MOUSE; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; DIFFERENTIATION ANTIGEN; MMP1 PROTEIN, HUMAN; MONOCROTALINE; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL INFILTRATION; CONTROLLED STUDY; HEART RIGHT VENTRICLE PRESSURE; HYPERPLASIA; LUNG ALVEOLUS; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CBA MOUSE; CELL PROLIFERATION; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; UPREGULATION;

ACTINS; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN; DISEASE MODELS, ANIMAL; HUMANS; HYPERPLASIA; HYPERTENSION, PULMONARY; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MONOCROTALINE; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; UP-REGULATION;

EID: 80555157658     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160295RET     Document Type: Erratum

References (34)

1. Lykouras, D., Sampsonas, F., Kaparianos, A., Efremidis, G., Karkoulias, K., Tsoukalas, G. and Spiropoulos, K. (2008) Pulmonary arterial hypertension: need to treat. Inflamm. Allergy Drug Targets 7, 260-269
2. Raiesdana, A. and Loscalzo, J. (2006) Pulmonary arterial hypertension. Ann. Med. 38, 95-110
3. Boutet, K., Montani, D., Jaïs, X., Yaïci, A., Sitbon, O., Simonneau, G. and Humbert, M. (2008) Therapeutic advances in pulmonary arterial hypertension. Ther. Adv. Respir. Dis. 2, 249-265
4. Davies, R. J. and Morrell, N. W. (2008) Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. Chest 134, 1271-1277
5. Tuder, R. M., Marecki, J. C., Richter, A., Fijalkowska, I. and Flores, S. (2007) Pathology of pulmonary hypertension. Clin. Chest Med. 28, 23-42
6. Rabinovitch, M. (2008) Molecular pathogenesis of pulmonary arterial hypertension. J. Clin. Invest. 118, 2372-2379
7. Farber, H. W. and Loscalzo, J. (2004) Pulmonary arterial hypertension. N. Engl. J. Med. 351, 1655-1665
8. Novotná, J. and Herget, J. (2002) Possible role of matrix metalloproteinases in reconstruction of peripheral pulmonary arteries induced by hypoxia. Physiol. Res. 51, 323-334
9. Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean,M. R., Lang, I.M., Christman, B.W.,Weir, E. K., Eickelberg, O., Voelkel, N. F. and Rabinovitch, M. (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 43, 13S-24S
10. Perros, F., Dorfmüller, P. and Humbert, M. (2005) Current insights on the pathogenesis of pulmonary arterial hypertension. Semin. Respir. Crit. Care Med. 26, 355-364
11. Frisdal, E., Gest, V., Vieillard-Baron, A., Levame, M., Lepetit, H., Eddahibi, S., Lafuma, C., Harf, A., Adnot, S. and Dortho, M. P. (2001) Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur. Respir. J. 18, 838-845
12. Zaidi, S. H., You, X. M., Ciura, S., Husain, M. and Rabinovitch, M. (2002) Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105, 516-521
13. Tajsic, T. and Morrell, N. W. (2011) Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension. Compr. Physiol. 1, 295-317
14. Wright, J. L., Tai, H., Wang, R., Wang, X. and Churg, A. (2007) Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-α signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L125-L133
15. Foronjy, R. F., Sun, J., Lemaitre, V. and D'Armiento, J. M. (2008) Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model. Hypertens. Res. 31, 725-735
16. Satoh, M. and Satoh, A. (2009) 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension. J. Pharm. Pharm. Sci. 11, 118s-130s
17. Kolettis, T., Vlahos, A. P., Louka, M., Hatzistergos, K. E., Baltogiannis, G. G., Agelaki, M. M., Mitsi, A. and Malamou-Mitsi, V. (2007) Characterisation of a rat model of pulmonary arterial hypertension. Hellenic J. Cardiol. 48, 206-210
18. Zhao, Y. D., Courtman, D. W., Deng, Y., Kugathasan, L., Zhang, Q. and Stewart, D. J. (2005) Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ. Res. 96, 442-450
19. George, J. and D'Armiento, J. (2011) Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice. J. Hypertens. 29, 299-308
20. Lemaître, V., O'Byrne, T. K., Borczuk, A. C., Okada, Y., Tall, A. R. and D'Armiento, J. (2001) ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J. Clin. Invest. 107, 1227-1234
21. Voelkel, N. F., Tuder, R. M. and Weir, E. K. (1997) Pathophysiology of primary pulmonary hypertension. Primary Pulmonary Hypertension (Rubin, L. and Rich, S., eds.), pp. 83-129, Marcel Dekker, New York
22. Pardo, A. and Selman, M. (2005) MMP-I: the elder of the family. Int. J. Biochem. Cell. Biol. 37, 283-288
23. Ohbayashi, H. (2002) Matrix metalloproteinases in lung diseases. Curr. Protein Pept. Sci. 3, 409-421
24. Lepetit, H., Eddahibi, S., Fadel, E., Frisdal, E., Munaut, C., Noel, A., Humbert, M., Adnot, S., D'Ortho, M. P. and Lafuma, C (2005) Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur. Respir. J. 25, 834-842
25. Csiszar, A., Labinskyy, N., Jo, H., Ballabh, P. and Ungvari, Z. (2008) Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 295, H569-H577
26. Humbert, M., Montani, D., Perros, F., Dorfmüller, P., Adnot, S. and Eddahibi, S. (2008) Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vasc. Pharmacol. 49, 113-118
27. Jeffery, T. K. and Morrell, N. W. (2002) Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog. Cardiovasc. Dis. 45, 173-202
28. Rabinovitch, M. (2007) Pathobiology of pulmonary hypertension. Annu. Rev. Pathol. Mech. Dis. 2, 369-399
29. Morrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K. and Trembath, R. C. (2001) Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-β1 and bone morphogenetic proteins. Circulation 104, 790-795
30. Lee, D. S., Kim, Y. K. and Jung, Y. W. (2010) Simvastatin, sildenafil and their combination in monocrotaline induced pulmonary arterial hypertension. Korean Circ. J. 40, 659-664
31. Hongo, M., Mawatari, E., Sakai, A., Ruan, Z., Koizumi, T., Terasawa, F., Yazaki, Y., Kinoshita, O., Ikeda, U. and Shibamoto, T (2005) Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats. J. Cardiovasc. Pharmacol. 46, 452-458
32. Chen, C. H., Poucher, S. M., Lu, J. and Henry, P. D. (2004) Fibroblast growth factor 2: from laboratory evidence to clinical application. Curr. Vasc. Pharmacol. 2, 33-43
33. Benisty, J. I., McLaughlin, V. V., Landzberg, M. J., Rich, J. D., Newburger, J.W., Rich, S. and Folkman, J. (2004) Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. Chest 126, 1255-1261
34. Asosingh, K., Aldred, M. A., Vasanji, A., Drazba, J., Sharp, J., Farver, C., Comhair, S. A., Xu, W., Licina, L., Huang, L. et al. (2008) Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am. J. Pathol. 172, 615-627